Repositorio Dspace

Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ?-lactamase-producing Enterobacterales in patients with diabetic foot infections requiring hospital admission

Mostrar el registro sencillo del ítem

dc.contributor.author García-Zafra, Victoria
dc.contributor.author Hernández-Torres, Alicia
dc.contributor.author García-Vázquez, Elisa
dc.contributor.author Soria-Cogollos, Teresa
dc.contributor.author Canteras-Jordana, Manuel
dc.contributor.author Ruiz-Gómez, Joaquín
dc.contributor.author Gómez-Gómez, Joaquín
dc.contributor.author Hernández-Martínez, Antonio
dc.contributor.author Barberan, José
dc.date.accessioned 2025-11-26T11:34:21Z
dc.date.available 2025-11-26T11:34:21Z
dc.date.issued 2020-12
dc.identifier.citation García Zafra V, Hernández Torres A, García Vázquez E, Soria Cogollos T, Canteras Jordana M, Ruiz Gómez J, et al. Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission. Rev Esp Quimioter. 30 de noviembre de 2020;33(6):430-5.
dc.identifier.issn 0214-3429
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22516
dc.description.abstract OBJECTIVE: Methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum ?-lactamase-producing Enterobacterales (ESBL-E) may complicate the treatment of diabetic foot infections (DFIs). The aim of this study was to determine the risk factors for these pathogens in DFIs. METHODS: This was a prospective observational study of 167 consecutive adult patients with DFIs. The diagnosis and severity of DFIs were based on the Infectious Disease Society of America (IDSA) classification system. Multivariate analyses were performed in order to identify risk factors for MRSA and ESBL-E infections. RESULTS: S. aureus was the most isolated pathogen (n=82, 37.9 %) followed by Escherichia coli (n= 40, 18.5%). MRSA accounted for 57.3% of all S. aureus and 70% of Klebsiella pneumoniae and 25% of E. coli were ESBL producers, respectively. Deep ulcer [OR 8,563; 95% CI (1,068-4,727)], previous use of fluoroquinolones [OR 2,78; 95% CI (1,156-6,685)] and peripheral vasculopathy [OR 2,47; 95% CI (1.068-4.727)] were the independent predictors for MRSA infections; and osteomyelitis [OR 6,351; 95% CI (1,609-25,068)] and previous use of cephalosporins [OR 5,824; 95% CI (1,517-22,361)] for ESBL-E infections. CONCLUSIONS: MRSA and ESBL-E have adquired a great clinical relevance in DFIs. The availability of their risk factors is very convenient to choose the empirical treatment in severe forms.
dc.language.iso eng
dc.publisher SOCIEDAD ESPANOLA QUIMIOTERAPIA
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0 *
dc.subject.mesh Adult
dc.subject.mesh Diabetes Mellitus
dc.subject.mesh Diabetic Foot/microbiology
dc.subject.mesh Escherichia coli
dc.subject.mesh Hospitals
dc.subject.mesh Humans
dc.subject.mesh Methicillin-Resistant Staphylococcus aureus
dc.subject.mesh Risk Factors
dc.subject.mesh beta-Lactamases
dc.title Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ?-lactamase-producing Enterobacterales in patients with diabetic foot infections requiring hospital admission
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 33246358
dc.relation.publisherversion https://seq.es/abstract/rev-esp-quimioter-2020-november-27-2/
dc.identifier.doi 10.37201/req/101.2020
dc.journal.title Revista Española de Quimioterapia
dc.identifier.essn 1988-9518


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta